Straits Times Index
3,344.06 -4.81 (-0.14%) Nikkei
38,825.59 -97.41 (-0.25%) Hang Seng
18,441.59 +38.59 (+0.21%) FTSE 100
8,262.75 -12.63 (-0.15%) Bitcoin USD
69,217.91 +941.20 (+1.38%) CMC Crypto 200
1,448.37 -19.57 (-1.33%)
Tandem Diabetes Care, Inc. (TNDM)
After hours:
| Previous close | 51.23 |
| Open | 53.66 |
| Bid | 51.94 x 500 |
| Ask | 52.09 x 400 |
| Day's range | 50.82 - 53.25 |
| 52-week range | 13.82 - 53.69 |
| Volume | |
| Avg. volume | 1,794,625 |
| Market cap | 3.357B |
| Beta (5Y monthly) | 1.10 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM
SAN DIEGO, May 29, 2024--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM), today announced that the Tandem Mobi insulin pump with Control-IQ technology is now fully compatible with both the Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems. Tandem Mobi, the world’s smallest, durable automated insulin delivery (AID) system1, launched in the United States earlier this year.
- Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentation
SAN DIEGO, May 23, 2024--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 8:00am Eastern Time (5:00am Pacific Time).
- Business Wire
Tandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial Guidance
SAN DIEGO, May 02, 2024--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2024 and increased sales guidance for the year ending December 31, 2024.
